Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Chow

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
The Journal of Experimental Medicine|May 4, 2011
Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantationDaigo Hashimoto, Andrew Chow, Melanie Greter, et al.
BMJ Open|April 7, 2016
Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitisProton Rahman, Denis Choquette, William G Bensen, et al.
Nature Immunology|October 2, 2012
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophagesEmmanuel L Gautier, Tal Shay, Jennifer Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host diseaseTeresa Ramirez-Montagut, Andrew Chow, Adam A Kochman, et al.
Immunity|July 4, 2012
GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cellsMelanie Greter, Julie Helft, Andrew Chow, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2022
Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLCEvelyn M Nguyen, Hirokazu Taniguchi, Joseph M Chan, et al.
Nature Immunology|July 17, 2012
Deciphering the transcriptional network of the dendritic cell lineageJennifer C Miller, Brian D Brown, Tal Shay, et al.
Science Advances|September 27, 2024
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancerHirokazu Taniguchi, Subhamoy Chakraborty, Nobuyuki Takahashi, et al.
Cell Reports|May 18, 2022
WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLCHirokazu Taniguchi, Rebecca Caeser, Shweta S Chavan, et al.
Immunity|April 23, 2013
Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytesDaigo Hashimoto, Andrew Chow, Clara Noizat, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
The Journal of Experimental Medicine|May 4, 2011
Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantationDaigo Hashimoto, Andrew Chow, Melanie Greter, et al.
BMJ Open|April 7, 2016
Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitisProton Rahman, Denis Choquette, William G Bensen, et al.
Nature Immunology|October 2, 2012
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophagesEmmanuel L Gautier, Tal Shay, Jennifer Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host diseaseTeresa Ramirez-Montagut, Andrew Chow, Adam A Kochman, et al.
Immunity|July 4, 2012
GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cellsMelanie Greter, Julie Helft, Andrew Chow, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2022
Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLCEvelyn M Nguyen, Hirokazu Taniguchi, Joseph M Chan, et al.
Nature Immunology|July 17, 2012
Deciphering the transcriptional network of the dendritic cell lineageJennifer C Miller, Brian D Brown, Tal Shay, et al.
Science Advances|September 27, 2024
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancerHirokazu Taniguchi, Subhamoy Chakraborty, Nobuyuki Takahashi, et al.
Cell Reports|May 18, 2022
WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLCHirokazu Taniguchi, Rebecca Caeser, Shweta S Chavan, et al.
Immunity|April 23, 2013
Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytesDaigo Hashimoto, Andrew Chow, Clara Noizat, et al.
Pageof 9